Back to Trades
Hoberman Kenneth
DirectorCIK 0001573722
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2026
Hoberman Kenneth, Director, accounts for 2 disclosed filings worth $0, spread across 2 companies, active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 15 | TGTX TG THERAPEUTICS, INC. | Hoberman Kenneth | Director | Award | $0 |
| Jun 12 | NVCT Nuvectis Pharma, Inc. | Hoberman Kenneth | Director | Grant | $0 |
2 filings